CV Sciences (CVSI) Interest Coverage Ratio Growth (1y) (2012 - 2026)
CV Sciences (CVSI) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -21.30% |
| 10 | CV Sciences | - | - | 1.56 Mn | -4,793.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,793.84% |
| Dec 31, 2025 | 122.11% |
| Sep 30, 2025 | 13.33% |
| Mar 31, 2019 | -11,565.12% |
| Dec 31, 2018 | 105,407.19% |
| Sep 30, 2018 | 2,691.65% |
| Jun 30, 2018 | 810.25% |
| Mar 31, 2018 | 148.86% |
| Dec 31, 2017 | 515.10% |
| Sep 30, 2017 | 9.52% |
| Jun 30, 2017 | 48.44% |
| Mar 31, 2017 | -722.52% |
| Dec 31, 2016 | -90.62% |
| Sep 30, 2016 | 36.45% |
| Jun 30, 2016 | 89.83% |
| Dec 31, 2015 | 102.57% |
| Dec 31, 2014 | -3,072.05% |
| Sep 30, 2013 | 45.39% |
| Jun 30, 2013 | -36.96% |
| Sep 30, 2012 | 32.46% |